Afternoon Symposium - How to Choose the Best Embryo—Proteomic, Metabolomic, Genomic, Imaging

Date:October 22, 2014

Time:3:45 pm - 5:45 pm

Location:HCC313 - Hawaii Convention Center

Presenters

Tien-cheng Arthur Chang, Ph.D. (Chair), University of Texas Health Science Center at San Antonio

Wayne A. Caswell, B.S., Fertility Centers of New England

Mandy Katz-Jaffe, Ph.D., Colorado Center for Reproductive Medicine

Nathan R. Treff, Ph.D., Reproductive Medicine Associates of New Jersey

Needs Assessment and Description
With the goal to help couples undergoing assisted reproductive technology (ART) treatments achieve a higher success rate and a lower number of multiple pregnancies, many technologies are being developed for embryo selection. The ideal technology will provide a reliable, cost- effective, and efficient predictive test of embryo viability and pregnancy outcome. This live session for reproductive laboratory professionals, physicians, genetic testing professionals, and other reproductive medicine clinicians and researchers will explore the updates and the latest trends in embryo selection technologies. 

Learning Objectives
At the conclusion of this session, participants should be able to: 

  1. Identify new technologies in embryo selection. 
  2. Describe the necessary and accumulating evidence to demonstrate the utility of comprehensive chromosome screening-based embryo selection. 
  3. Discuss the importance of and methodology for controlling the multiple known and unknown variables that may impact embryonic reproductive potential. 
  4. Explore current proteomics and metabolomics techniques that are being developed for embryo selection in in vitro fertilization (IVF). 
  5. Identify the applications and potential benefits of time-lapse technology, and emerging research in the use of time-lapse imaging. 
ACGME Competency
Medical Knowledge
Practice-based Learning and Improvement 

TEST QUESTION
What does the non-selection clinical trial help to establish?
a. The predictive value of the test for actual clinical outcomes
b. The clinical efficacy of a new biomarker
c. The impact of the intervention on the embryo’s reproductive potential
d. The preclinical accuracy of the test

ASRM MEMBERSHIP

View Details
Learn More | Join | Renew
Back to Top